These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 28946966

  • 1. Value of urinary levels of interleukin-6, epidermal growth factor, monocyte chemoattractant protein type1 and transforming growth factor β1 in predicting the extent of fibrosis lesions in kidney biopsies of patients with IgA nephropathy.
    Segarra-Medrano A, Carnicer-Caceres C, Valtierra-Carmeno N, Agraz-Pamplona I, Ramos-Terrades N, Jatem Escalante E, Ostos-Roldan E.
    Nefrologia; 2017; 37(5):531-538. PubMed ID: 28946966
    [Abstract] [Full Text] [Related]

  • 2. Urinary levels of epidermal growth factor, interleukin-6 and monocyte chemoattractant protein-1 may act as predictor markers of renal function outcome in immunoglobulin A nephropathy.
    Stangou M, Alexopoulos E, Papagianni A, Pantzaki A, Bantis C, Dovas S, Economidou D, Leontsini M, Memmos D.
    Nephrology (Carlton); 2009 Sep; 14(6):613-20. PubMed ID: 19143943
    [Abstract] [Full Text] [Related]

  • 3. Urine Epidermal Growth Factor, Monocyte Chemoattractant Protein-1 or Their Ratio as Biomarkers for Interstitial Fibrosis and Tubular Atrophy in Primary Glomerulonephritis.
    Worawichawong S, Worawichawong S, Radinahamed P, Muntham D, Sathirapongsasuti N, Nongnuch A, Assanatham M, Kitiyakara C.
    Kidney Blood Press Res; 2016 Sep; 41(6):997-1007. PubMed ID: 27988512
    [Abstract] [Full Text] [Related]

  • 4. Accuracy of Urinary Epidermal Growth Factor to Creatinine Ratio to Predict 24-Hour Urine Epidermal Growth Factor and Interstitial Kidney Fibrosis in Patients with IgA Nephropathy.
    Segarra A, Carnicer C, Jatem E, Martin M, Molina M, Perich C, Martinez C.
    Clin Lab; 2019 Jun 01; 65(6):. PubMed ID: 31232037
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy.
    Torres DD, Rossini M, Manno C, Mattace-Raso F, D'Altri C, Ranieri E, Pontrelli P, Grandaliano G, Gesualdo L, Schena FP.
    Kidney Int; 2008 Feb 01; 73(3):327-33. PubMed ID: 17943082
    [Abstract] [Full Text] [Related]

  • 7. Steroid therapy and urinary transforming growth factor-beta1 in IgA nephropathy.
    Haramaki R, Tamaki K, Fujisawa M, Ikedo H, Haramaki N, Okuda S.
    Am J Kidney Dis; 2001 Dec 01; 38(6):1191-8. PubMed ID: 11728950
    [Abstract] [Full Text] [Related]

  • 8. T helper (Th)-cytokines in the urine of patients with primary glomerulonephritis treated with immunosuppressive drugs: Can they predict outcome?
    Kalavrizioti D, Gerolymos M, Rodi M, Kalliakmani P, Provatopoulou S, Eleftheriadis T, Mouzaki A, Goumenos DS.
    Cytokine; 2015 Dec 01; 76(2):260-269. PubMed ID: 26307557
    [Abstract] [Full Text] [Related]

  • 9. [Changes of urinary monocyte chemotactic protein 1 and epidermal growth factor and their correlations with clinicopathology in idiopathic membranous nephropathy patients].
    Zheng S, Zhao ZH, Liu ZJ, Wang DH, Liu DW, Liu ZS.
    Zhonghua Yi Xue Za Zhi; 2020 Apr 28; 100(16):1230-1234. PubMed ID: 32344494
    [Abstract] [Full Text] [Related]

  • 10. Urinary IL-6/EGF ratio: a useful prognostic marker for the progression of renal damage in IgA nephropathy.
    Ranieri E, Gesualdo L, Petrarulo F, Schena FP.
    Kidney Int; 1996 Dec 28; 50(6):1990-2001. PubMed ID: 8943482
    [Abstract] [Full Text] [Related]

  • 11. Clinical value of inflammatory urinary biomarkers in overt diabetic nephropathy: a prospective study.
    Verhave JC, Bouchard J, Goupil R, Pichette V, Brachemi S, Madore F, Troyanov S.
    Diabetes Res Clin Pract; 2013 Sep 28; 101(3):333-40. PubMed ID: 23880038
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of TGF-β1 and MCP-1 expression and tubulointerstitial fibrosis in children with Henoch-Schönlein purpura nephritis and IgA nephropathy: A clinical correlation.
    Shuiai Z, Huijun S, Weizhong G, Aimin L, Jianhua M.
    Clinics (Sao Paulo); 2017 Feb 01; 72(2):95-102. PubMed ID: 28273242
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Urine excretion of a monocytic chemotaxic protein-1 and a transforming growth factor beta1 as an indicator of chronic glomerulonephritis progression].
    Bobkova IN, Chebotareva NV, Kozlovskaia LV, Varshavskiĭ VA, Golitsyna EP.
    Ter Arkh; 2006 Feb 01; 78(5):9-14. PubMed ID: 16889042
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Usefulness of urinary biomarkers to estimate the interstitial fibrosis surface in diabetic nephropathy with normal kidney function.
    González J, Jatem E, Roig J, Valtierra N, Ostos E, Abó A, Santacana M, García A, Segarra A.
    Nephrol Dial Transplant; 2022 Oct 19; 37(11):2102-2110. PubMed ID: 35583251
    [Abstract] [Full Text] [Related]

  • 17. Roles of TGF-beta1 and apoptosis in the progression of glomerulosclerosis in human IgA nephropathy.
    Chihara Y, Ono H, Ishimitsu T, Ono Y, Ishikawa K, Rakugi H, Ogihara T, Matsuoka H.
    Clin Nephrol; 2006 Jun 19; 65(6):385-92. PubMed ID: 16792132
    [Abstract] [Full Text] [Related]

  • 18. MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy.
    Grandaliano G, Gesualdo L, Bartoli F, Ranieri E, Monno R, Leggio A, Paradies G, Caldarulo E, Infante B, Schena FP.
    Kidney Int; 2000 Jul 19; 58(1):182-92. PubMed ID: 10886563
    [Abstract] [Full Text] [Related]

  • 19. Urinary interleukin-6 (IL-6) and transforming growth factor (TGF-β) levels in corticosteroidtreated patients with IgA nephropathy.
    Kalliakmani P, Nakopoulou L, Tsakas S, Gerolymos M, Papasotiriou M, Goumenos DS.
    Clin Nephrol; 2011 Aug 19; 76(2):144-50. PubMed ID: 21762647
    [Abstract] [Full Text] [Related]

  • 20. Is it possible to predict parameters of the Oxford classification of primary IgA Nephropathy from clinical laboratory data? Focus on the role of segmental glomerulosclerosis subtypes.
    Monteiro MLGDR, Vieira MR, Pereira LHM, Araújo LS, Silva CA, Araújo LB, Rocha LP, Reis MAD, Machado JR.
    Pathol Res Pract; 2019 Oct 19; 215(10):152533. PubMed ID: 31320251
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.